Literature DB >> 24421476

Delirium: ramelton.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Entities:  

Year:  2013        PMID: 24421476      PMCID: PMC3839455          DOI: 10.1310/hpj4804-280

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  4 in total

1.  Treatment of delirium with ramelteon: initial experience in three patients.

Authors:  Ryo Kimura; Kohji Mori; Hirokazu Kumazaki; Makoto Yanagida; Satoki Taguchi; Hidenori Matsunaga
Journal:  Gen Hosp Psychiatry       Date:  2011-05-20       Impact factor: 3.238

2.  Marked improvement in delirium with ramelteon: five case reports.

Authors:  Motohide Furuya; Tsuyoshi Miyaoka; Hideaki Yasuda; Satoko Yamashita; Ippei Tanaka; Shoko Otsuka; Rei Wake; Jun Horiguchi
Journal:  Psychogeriatrics       Date:  2012-12       Impact factor: 2.440

3.  Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.

Authors:  Tsuyoshi Ohta; Kenichi Murao; Kosuke Miyake; Koichiro Takemoto
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-25       Impact factor: 2.136

Review 4.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.